Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03398967
Brief Title: A Feasibility and Safety Study of Universal Dual Specificity CD19 and CD20 or CD22 CAR-T Cell Immunotherapy for Relapsed or Refractory Leukemia and Lymphoma

First Submitted : January 8, 2018
First Submitted that Met QC Criteria : January 8, 2018
First Posted : January 16, 2018

Last Update Submitted that Met QC Criteria : January 8, 2018
Last Update Posted : January 16, 2018